Clinical Guideline Adult Preventive (21 & Over)

Transcription

1 COUNSELING SCREENING Clinical Indicator Ages Ages Ages Ages 65+ Assessing tobacco use Every visit Every visit Every visit Every visit Advising smokers to quit At least annually At least annually At least annually At least annually Assess drug/alcohol use 1 Annually Annually Annually Annually Depression screening 2 Annually Annually Annually Annually Assess STD risk Annually Annually Annually Annually Assessment of functional status Annually Assessment of fall risk Annually if high risk Annually Pain assessment Annually Medication review Annually Annually Annually Annually Advance care planning Annually Annually Annually Annually Discussion of aspirin prophylaxis 3 If high risk: Men-annually Women-post menopausal Annually if high risk Annually if high risk Preventive screening evaluation Every visit Every visit Every visit Every visit Blood Pressure Every visit Every visit Every visit Every visit Cervical cancer screening 4 (Pap) At a minimum every three At a minimum every three At a minimum every three Women: high risk years, more frequently if in years, more frequently if in years, more frequently if in a a high risk group a high risk group high risk group HPV 5 Women: age 30 if Women: age 30 if Women: age 30 if indicated Women high risk indicated indicated Mammogram 6 Women: every 2 years until Women: every 2 years Abdominal Aortic Aneurysm Screening 7 the age of 75 Chlamydia screening 8 Women: annually to age 24 If high risk If high risk & with Pregnancy Discuss prostate cancer screening 9 Annually Annually Annually Colorectal cancer screening by any of the following methods: 10 Fecal occult blood (high sensitivity) or until the age of 75 Men aged 65 to 75 who have ever smoked (Onetime screening) Annually Annually until age 75 Fecal Immunochemical Test-DNA or Every 3 years Every 3 years until age 75 Sigmoidoscopy or Every 5 years Every 5 years until age 75 Colonoscopy Every 10 years until age Every 10 years 75 Page 1 of 4

2 Vision, Hearing Every 5 years Men 20: every 5 years Men: every 5 years unless 11 Lipid Profile unless high risk high risk Every 5 years unless high Women age 45: every 5 risk If not checked previously years unless high risk Obesity screening (BMI) 12 Every visit Every visit Every visit Every visit Domestic violence 13 Annually Annually Annually Annually Osteoporosis Screening greater than that of a 65- year-old white woman with no additional risk factors. greater than that of a 65- year-old white woman with no additional risk factors. greater than that of a 65-yearold white woman with no additional risk factors. At age 65, provide BMD testing if not previously tested. Evidence is lacking about optimal intervals for repeated screening Hepatitis C Screening One time screening for those aged One time screening for those aged HIV screening At least once or annually if Bladder control/ incontinence Annually Diabetes screening w/out prior diagnosis HbA1C 14 at risk at risk At least once or annually if at risk until age 70 Diabetes screening w/ prior diagnosis HbA1C, dilated retinal examination, and microalbumin/ nephropathy testing 15 At least once annually At least once annually At least once annually At least once annually Page 2 of 4

3 Gateway Health Plan follows the Centers for Disease Control and Prevention, recommended Adult Immunization Schedule-United States, IMMUNIZATIONS Recommended Adult Immunization Schedule has been approved by ACIP, ACOG, ACP & AAFP. Please see attachment. Immunization Link: 1 Use CAGE screening. C: Have you ever felt you ought to Cut down on drinking? A: Have people Annoyed you by criticizing your drinking? G: Have you ever felt bad or Guilty about your drinking? E: Have you ever had a drink first thing in the morning to steady your nerves or get rid of a hangover (Eye opener)? 2 Screening questions are: Over the past month have you felt down, depressed or hopeless and Over the past month have you felt little interest or pleasure in doing things. 3 Aspirin prophylaxis high risk-diabetes, elevated cholesterol levels, low levels of HDL cholesterol, elevated blood pressure, family history and smoking. 4 Discontinuation of cervical cancer screening in older women is appropriate, provided women have had adequate recent screening with normal Pap results. Screening is recommended in older women who have not been previously screened, when information about previous screening is unavailable or when screening is unlikely to have been done in the past. Recommendations from various organizations differ in how often the Pap screen should be done. The general recommendation is to screen every 2-3 years after 3 years of being sexually active but not later than age 21. Women ages may only need to be screened every 5 years if the Pap test is done in combination with HPV testing. 5 Although the United States Preventive Services Task Force found insufficient evidence to recommend for or against screening, other organizations endorsed routine screening along with Pap tests for women age 30 and older. 6 There is controversy over how often and at what age the mammograms should be done. Various agencies recommend starting annual screening at age 40 for all women, other agencies say to start at age 50. The included recommendation is based off of current United States Preventive Services Task Force guidelines. The United States Preventive Services Task Force also suggests that screening starting at age 40 may benefit high risk women. 7 United States Preventive Services Task Force 8 Chlamydia screening high risk Prevalence is higher in the following populations: unmarried women, African American race, prior history of STD, having new or multiple sex partners, having cervical ectopy using barrier contraceptives inconsistently, and partners having multiple partners who engage in high risk behavior. Page 3 of 4

4 9 The American Urological Association recommends shared decision making with men on the use of PSA for screening. Men ages at high risk and men at average risk ages with a life expectancy > 10 years who decide to include PSA should have routine screening every two years. PSA screening is not recommended for men ages United States Preventive Services Task Force recommends against routine screening for colorectal cancer in adults There may be considerations that support colorectal cancer screening in an individual patient. 11 Lipid disorder high risk diabetes, history of cardiovascular disease before age 50 in male relatives or age 60 in female relatives, history suggestive of familial hyperlipidemia, multiple coronary heart disease risk factors and people who have lipid levels close to those warranting treatment. 12 Assess BMI and waist circumference at every visit during which weight is measured. Use 5As: Ask if patient is ready to make a change. Advise in a clear, specific and tailored manner. Assess level of obesity and co morbidities. Assist by providing necessary tools and support. Arrange contact with other providers who can provide a team approach. 13 At each visit ask: Within the past year have you been hit, slapped, kicked or otherwise physically hurt by someone? Are you in a relationship with a person who physically hurts you? Has anyone forced you to have sexual activities that make you feel uncomfortable? 14 Men and women ages years who have at least one risk factor should be screened at least once annually. Risk factors include a BMI > 25, history of smoking, or a prior abnormal A1C. Abnormal A1C tests should receive follow-up within 3-6 months. 15 Microalbumin/ nephropathy testing should occur annually if results are negative. Positive results should receive follow-up testing within 3-6 months. Clinical Indicators: 1. The percentage of women years of age who had a mammogram to screen for breast cancer. (Source: HEDIS 2017, Vol. 2, Technical Specifications, BCS) 2. The percentage of members years of age who had an outpatient visit and whose body mass index (BMI) was documented during the measurement year or the year prior to the measurement year. (Source: HEDIS 2017, Vol. 2, Technical Specifications, ABA) Description of the Indicator Page 4 of 4

5 Scientific Evidence Sources: U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. Washington, DC: Office of Disease Prevention and Health Promotion, U.S. Government Printing Office, U.S. Preventive Services Task Force. Recommendations and Rationale: Screening for Depression (2009), Screening for Colorectal Cancer (2017), Screening for Breast Cancer (2016), Behavioral Counseling in Primary Care to Promote Physical Activity (2012), and Aspirin for the Primary Prevention of Cardiovascular Events. (2009), Screening for Cervical Cancer (2012), Screening for Obesity in Adults (2012), Osteoporosis Screening (2011) Screening for Family and Intimate Partner Violence (2013) Screening for Alcohol Misuse (April 2004) American Urological Association Recommendation on the Use of PSA for Detection of Prostate Cancer (2013) American Academy of Family Practice Physicians Panel on Obesity, October 7, 2005 American Academy of Family Physicians. Summary of Recommendations for Clinical Preventive Services, October 2012 The Advisory Committee on Immunization Practices. Recommended Adult Immunization Schedule United States, 2013 National Osteoporosis Foundation :Clinician s Guide to Prevention and Treatment of Osteoporosis, 2010 American College of Obstetricians and Gynecologists: Cervical Cytology Screening, Clinical Bulletin No.109 Health Care Guideline: Preventive Services for Adults: Institute for Clinical Systems Improvement; 2012 Well-woman visit. Committee Opinion No American College of Obstetricians and Gynecologists. Obstet Gynecol. 2012;120: Fleming C, Whitlock EP, Beil T, Lederle F. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2005;142: The Journal of Clinical And Applied Research And Education: Diabetes Care: American Diabetes Association: Standards of Medical Care in Diabetes-2016 Volume 39, January 2016 Page 5 of 4